Bicara Therapeutics Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -51.98M-67.99M
Depreciation and Depletion 0.02M0.06M
Share-based Compensation 1.90M7.40M
Gains from Investment Securities 0.70M0.41M
Asset Writedowns and Impairment 0.57M
Cash from Operations -45.63M-74.75M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.02M0.06M
Change in Working Capital
Change in Accured Expenses -12.46M6.63M
Investing Activities
Capital Expenditures 0.59M0.07M
Sales of Property, Plant and Equipment 0.06M
Cash from Investing Activities -0.59M-0.01M
Financing Activities
Change in Capital Stock
Shares Issued 0.15M332.43M
Preferred Shares Issued 272.30M
Misc.
Cash from Financing Activities 272.50M334.03M
Change in Cash 226.28M259.27M
Free Cash Flow -46.21M-74.82M
Net Cash Flow 226.28M259.27M